Among malignant tumors, adenocarcinomas of the esophagogastric junction show the highest increase in incidence over the past three decades in Western industrialized countries. This special volume, with contributions from experts in the field, covers all aspects of the disease. Etiology, pathogenesis, classification, and clinical staging are discussed, and there is special emphasis on state of the art treatment techniques. The latter range from endoscopic mucosal resections or limited surgical resections for early cancers to multimodality treatment options for locally advanced tumors. Emerging quality issues in surgical management are addressed. Detailed attention is also paid to other important recent developments, including molecular response prediction, early metabolic response evaluation by PET and PET-CT, the diagnosis of micrometastases, and the use of sentinel node technology. This volume will be of interest to all clinicians concerned with the diagnosis and management of this malignancy.

Epidemiology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third

Clinical Classification Systems of Adenocarcinoma of the Esophagogastric Junction
Histopathologic Classification of Adenocarcinoma of the Esophagogastric Junction
The Pathogenesis of Barrett's Metaplasia and the Progression to Esophageal Adenocarcinoma
Differences in the Molecular Biology of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third
Clinical Staging of Adenocarcinoma of the Esophagogastric Junction
Endoscopic Mucosal Resection for Staging and Therapy of Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third
Surgical Strategies for Adenocarcinoma of the Esophagogastric Junction
Current Status of Sentinel Lymph Node Biopsy in Adenocarcinoma of the Distal Esophagus, Gastric Cardia, and Proximal Stomach
Current Diagnosis and Future Impact of Micrometastases for Therapeutic Strategies in Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third
Quality Indicators of Surgery for Adenocarcinoma of the Esophagus and Gastroesophageal Junction
Peri-Operative and Complication Management for Adenocarcinoma of the Oesophagus and Oesophagigastric Junction
Multimodality Therapy for Adenocarcinoma of the Esophagus, Gastric Cardia, and Upper Gastric Third
Metabolic Response Evaluation by PET During Neoadjuvant Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction
Molecular Response Prediction in Multimodality Treatment for Adenocarcinoma of the Esophagus and Esophagogastric Junction.